429 results on '"Gebo, Kelly A"'
Search Results
2. Discordant performance of mpox serological assays
3. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study
4. Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation
5. Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study
6. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
7. Mpox in people with advanced HIV infection: a global case series
8. Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort
9. The All of Us Research Program: Data quality, utility, and diversity
10. Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
11. Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States
12. Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
13. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities
14. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study
15. Accuracy of Provider Predictions of Viral Suppression Among Adolescents and Young Adults With HIV in an HIV Clinical Program.
16. Ending the HIV epidemic in the USA: an economic modelling study in six cities
17. Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD
18. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
19. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
20. Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.
21. Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005–2018: A Collaboration of Cohort Studies.
22. The association of a scholarly concentrations program with medical students' matched residencies.
23. Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox.
24. Brief Report: Hospitalization Rates Among Persons With HIV Who Gained Medicaid or Private Insurance After the Affordable Care Act in 2014
25. Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
26. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers
27. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010
28. Higher Acuity Resource Utilization With Older Age and Poorer HIV Control in Adolescents and Young Adults in the HIV Research Network
29. Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act
30. HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014–2015
31. Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program.
32. Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine.
33. Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample.
34. Aging and Loss to Follow-up Among Youth Living With Human Immunodeficiency Virus in the HIV Research Network
35. Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection
36. The Lifetime Medical Cost Savings From Preventing HIV in the United States
37. Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults
38. Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators
39. Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004–2014
40. Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data
41. Hepatitis C Viremia and the Risk of Chronic Kidney Disease in HIV-Infected Individuals
42. The Impact of Combined Antiretroviral Therapy on Biologic False-Positive Rapid Plasma Reagin Serologies in a Longitudinal Cohort of HIV-Infected Persons
43. Retention in Care and Health Outcomes of Transgender Persons Living With HIV
44. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
45. Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment.
46. Factors Associated With Retention Among Non–Perinatally HIV-Infected Youth in the HIV Research Network
47. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America
48. Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001–2009
49. Reply to Holtzman and Gallagher
50. The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.